US regulators on Thursday approved the first drug to treat Covid-19: remdesivir, an antiviral medicine given to hospitalised patients through an IV.The drug, which California-based Gilead Sciences is calling Veklury, cut the time...
Full ArticleCovid 19 coronavirus: FDA approves first drug: antiviral remdesivir
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
Nvidia & darpa biohybrid
Rumble
https://www.youtube.com/watch?v=0Hg7XhbXuac . No One is Talking About What Just Happened..
-
NA Proactive news snapshot: ElectraMeccanica Vehicles, Willow Biosciences, DRDGOLD Limited, Aurania Resources UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: DGTL Holdings, First Cobalt, American Resources, Progressive Planet, Silver Range Resources, African Gold Group UPDATE...
Proactive Investors
-
Humanigen says first patient dosed in NIH-run ACTIV-5 ‘Big Effect Trial’ evaluating lenzilumab for COVID-19
Proactive Investors
-
BetterLife Pharma to conduct telemedicine coronavirus trials of AP-003 to ease access for patients
Proactive Investors
Advertisement
More coverage
New COVID-19 Cases And Hospitalizations Up; Deaths May Follow
Newsy
Watch VideoHospitals are bracing for another surge of COVID-19 patients. In parts of Texas, COVID-19 hospitalizations have roughly..
-
United States: FDA Approves Veklury (Remdesivir) As The First Treatment For COVID-19 - Seyfarth Shaw LLP
Mondaq
-
Predictmedix hopes to roll out its telemedicine platform Mobile Wellbeing in first quarter of 2021
Proactive Investors
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors